Stocker Hannah, Gentiluomo Manuel, Trares Kira, Beyer Léon, Stevenson-Hoare Joshua, Rujescu Dan, Holleczek Bernd, Beyreuther Konrad, Gerwert Klaus, Schöttker Ben, Campa Daniele, Canzian Federico, Brenner Hermann
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
Network Aging Research, Heidelberg University, Heidelberg, Germany.
Mol Psychiatry. 2025 Jan;30(1):131-139. doi: 10.1038/s41380-024-02670-x. Epub 2024 Jul 15.
The mitochondrial cascade hypothesis of Alzheimer's disease (AD) has been portrayed through molecular, cellular, and animal studies; however large epidemiological studies are lacking. This study aimed to explore the association of mitochondrial DNA copy number (mtDNAcn), a marker representative of mtDNA abundance per cell, with risk of incident all-cause dementia, AD, and vascular dementia diagnosis within 17 years and dementia-related blood biomarkers (P-tau181, GFAP, and NfL). Additionally, sex-stratified analyses were completed. In this German population-based cohort study (ESTHER), 9940 participants aged 50-75 years were enrolled by general practitioners and followed for 17 years. Participants were included in this study if information on dementia status and blood-based mtDNAcn measured via real-time polymerase chain reaction were available. In a nested case-control approach, a subsample of participants additionally had measurements of P-tau181, GFAP, and NfL in blood samples taken at baseline. Of 4913 participants eligible for analyses, 386 were diagnosed with incident all-cause dementia, including 130 AD and 143 vascular dementia cases, while 4527 participants remained without dementia diagnosis within 17 years. Participants with low mtDNAcn (lowest 10%) experienced 45% and 65% percent increased risk of incident all-cause dementia and AD after adjusting for age and sex (all-cause dementia: HRadj, 95%CI:1.45, 1.08-1.94; AD: HRadj, 95%CI: 1.65, 1.01-2.68). MtDNAcn was not associated to vascular dementia diagnosis and was more strongly associated with all-cause dementia among women. In the nested case-control study (n = 790), mtDNAcn was not significantly associated with the dementia-related blood biomarkers (P-tau181, GFAP, and NfL) levels in blood from baseline before dementia diagnosis. This study provides novel epidemiological evidence connecting mtDNA abundance, measured via mtDNAcn, to incident dementia and AD at the population-based level. Reduced mitochondrial abundance may play a role in pathogenesis, especially among women.
阿尔茨海默病(AD)的线粒体级联假说已通过分子、细胞和动物研究得以描述;然而,大型流行病学研究尚缺。本研究旨在探讨线粒体DNA拷贝数(mtDNAcn)这一代表每个细胞中线粒体DNA丰度的标志物与17年内全因性痴呆、AD和血管性痴呆诊断风险以及与痴呆相关的血液生物标志物(P-tau181、GFAP和NfL)之间的关联。此外,还完成了按性别分层的分析。在这项基于德国人群的队列研究(ESTHER)中,9940名年龄在50 - 75岁的参与者由全科医生招募并随访17年。如果有痴呆状态信息以及通过实时聚合酶链反应测量的血液中mtDNAcn信息,参与者就被纳入本研究。采用巢式病例对照方法,一部分参与者在基线采集的血液样本中还额外测量了P-tau181、GFAP和NfL。在4913名符合分析条件的参与者中,386人被诊断为新发全因性痴呆,包括130例AD和143例血管性痴呆病例,而4527名参与者在17年内未被诊断出患有痴呆。mtDNAcn较低(最低10%)的参与者在调整年龄和性别后,发生全因性痴呆和AD的风险分别增加了45%和65%(全因性痴呆:校正后风险比[HRadj],95%置信区间[CI]:1.45,1.08 - 1.94;AD:HRadj,95%CI:1.65,1.01 - 2.68)。mtDNAcn与血管性痴呆诊断无关,且在女性中与全因性痴呆的关联更强。在巢式病例对照研究(n = 790)中,mtDNAcn与痴呆诊断前基线血液中与痴呆相关的血液生物标志物(P-tau181、GFAP和NfL)水平无显著关联。本研究提供了新的流行病学证据,在基于人群的水平上,将通过mtDNAcn测量的线粒体丰度与新发痴呆和AD联系起来。线粒体丰度降低可能在发病机制中起作用,尤其是在女性中。